Skip to main
BCAX

BCAX Market Capitalization Overview

Market Cap: $983.34M as of Jan 9, 2026

$983.34M
$51.50M (4.98%)past month
As of Jan 9, 2026, BCAX has a market capitalization of $983.34M. Over the past 30 days, its market cap has decreased by -5.48%, while in the last 12 months, it has increased by 6.65%.

Market capitalization represents the total value of Bicara Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

BCAX Market Cap Formula = Stock Price * Shares Outstanding

The market cap of BCAX helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BCAX Market Cap History

DateMarket CapChange
Dec 1, 2025$949.38M+8.78%
Nov 3, 2025$872.71M-3.71%
Oct 1, 2025$906.29M+39.58%
Sep 2, 2025$649.30M+13.07%
Aug 1, 2025$574.27M+11.31%
Jul 1, 2025$515.92M-4.44%
Jun 2, 2025$539.91M-32.70%
May 1, 2025$802.23M+16.45%
Apr 1, 2025$688.91M-0.31%
Mar 3, 2025$691.08M+3.25%
Feb 3, 2025$669.32M-27.33%
Jan 2, 2025$920.99M-15.41%

BCAX End of Year Market Cap History

DateMarket CapChange
2026$983.34M+6.65%
2025$921.99M-2.74%
2024$947.92M

FAQs About Bicara Therapeutics Inc (BCAX) Market Cap

As of Jan 9, 2026, the market capitalization of BCAX is $983.34M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Bicara Therapeutics Inc’s market capitalization has decreased by -4.98%, changing from $1.04B to $983.34M as of Jan 9, 2026.

In the last 3 months, Bicara Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Bicara Therapeutics Inc’s market capitalization decreased from $947.92M in January to $921.99M in December, reflecting a -2.74% change.

In the past five years, BCAX has had a compound annual growth rate (CAGR) of -1.38% in market capitalization. This means its market cap has shrunk at an average rate of -1.38% per year.

Bicara Therapeutics Inc (BCAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.